184 related articles for article (PubMed ID: 23300866)
1. Thyroid cancer risk is not increased in diabetic patients.
Tseng CH
PLoS One; 2012; 7(12):e53096. PubMed ID: 23300866
[TBL] [Abstract][Full Text] [Related]
2. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.
Tseng CH
PLoS One; 2014; 9(10):e109852. PubMed ID: 25303400
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes.
Tseng CH
Ann Med; 2013 Dec; 45(8):539-44. PubMed ID: 24215589
[TBL] [Abstract][Full Text] [Related]
4. Diabetes, insulin use and Helicobacter pylori eradication: a retrospective cohort study.
Tseng CH
BMC Gastroenterol; 2012 May; 12():46. PubMed ID: 22571603
[TBL] [Abstract][Full Text] [Related]
5. Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.
Tseng CH
BMC Cancer; 2013 Jan; 13():7. PubMed ID: 23286275
[TBL] [Abstract][Full Text] [Related]
6. Diabetes but not insulin increases the risk of lung cancer: a Taiwanese population-based study.
Tseng CH
PLoS One; 2014; 9(7):e101553. PubMed ID: 24991802
[TBL] [Abstract][Full Text] [Related]
7. Type 2 Diabetes Mellitus and Kidney Cancer Risk: A Retrospective Cohort Analysis of the National Health Insurance.
Tseng CH
PLoS One; 2015; 10(11):e0142480. PubMed ID: 26559055
[TBL] [Abstract][Full Text] [Related]
8. Risk of bladder cancer in diabetic patients treated with rosiglitazone or pioglitazone: a nested case–control study.
Hsiao FY; Hsieh PH; Huang WF; Tsai YW; Gau CS
Drug Saf; 2013 Aug; 36(8):643-9. PubMed ID: 23797604
[TBL] [Abstract][Full Text] [Related]
9. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
Chen CH; Lin CL; Hsu CY; Kao CH
QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan.
Hsiao FY; Huang WF; Wen YW; Chen PF; Kuo KN; Tsai YW
Drug Saf; 2009; 32(8):675-90. PubMed ID: 19591532
[TBL] [Abstract][Full Text] [Related]
11. Oral cancer in Taiwan: is diabetes a risk factor?
Tseng CH
Clin Oral Investig; 2013 Jun; 17(5):1357-64. PubMed ID: 22895832
[TBL] [Abstract][Full Text] [Related]
12. Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study.
Lee YC; Chang CH; Dong YH; Lin JW; Wu LC; Hwang JS; Chuang LM
Int J Cardiol; 2017 Feb; 228():1007-1014. PubMed ID: 27923207
[TBL] [Abstract][Full Text] [Related]
13. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus.
Chang CH; Lin JW; Wu LC; Lai MS; Chuang LM; Chan KA
Hepatology; 2012 May; 55(5):1462-72. PubMed ID: 22135104
[TBL] [Abstract][Full Text] [Related]
14. Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan.
Tseng CH
Eur J Endocrinol; 2012 Sep; 167(3):409-16. PubMed ID: 22778198
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study.
Wahlqvist ML; Lee MS; Chuang SY; Hsu CC; Tsai HN; Yu SH; Chang HY
BMC Med; 2012 Nov; 10():150. PubMed ID: 23194378
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone and oral cancer risk in patients with type 2 diabetes.
Tseng CH
Oral Oncol; 2014 Feb; 50(2):98-103. PubMed ID: 24239280
[TBL] [Abstract][Full Text] [Related]
18. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
19. Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and breast cancer in Taiwanese women: a detection bias?
Tseng CH
Eur J Clin Invest; 2014 Oct; 44(10):910-7. PubMed ID: 25104332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
